www.alldocs.info « cancers »
by www.alldocs.info
the most recent document references on :: cancers
Google
 
 Web   cancers.alldocs.info 
 
    Languages: malattie oncologiche  cancers  cancer  cancer  Krebse          Found 1931 documents         Page 10 of 65   Pages:  <<  <  5  6  7  8  9  10  11  12  13  14  15  >  >> 
 
 
 
   cancers cancers
     bladder cancer bladder cancer
     brain cancer brain cancer
     breast cancer breast cancer
     colon cancer colon cancer
     gastrointestinal cancer gastrointestinal cancer
     kidney cancer kidney cancer
     laryngeal cancer laryngeal cancer
     leukaemia leukaemia
     liver cancer liver cancer
     lung cancer lung cancer
     lymphoma lymphoma
     myeloma myeloma
     neuroblastoma neuroblastoma
     ovarian cancer ovarian cancer
     pancreatic cancer pancreatic cancer
     prostate cancer prostate cancer
     stomach cancer stomach cancer
     testicular cancer testicular cancer
     thyroid cancer thyroid cancer
     uterine cancer uterine cancer
     prevention prevention
     diagnosis diagnosis
     therapies therapies
  cancers.alldocs.infohomepage
www.alldocs.infowww.alldocs.info


 

  Legenda: last week last month

  [271] General Pathology 8 January 26, Wednesday, 2005 Masashi Fukayama ...
      PDF [47,1 KB]  From [ocw.u-tokyo.ac.jp]  Last viewed: 07.09.2006
General Pathology 8 January 26, Wednesday, 2005 Masashi Fukayama Basics of tumor pathology I. Molecular pathology of tumors A. Biology of tumors classical definition: lesions generated by “ autonomic ” proliferation of a cell, the proliferation continues after the removal of a stimulus basic nature of tumors : tumors are monoclonal. biological features of tumor cells: transplantable / infinite proliferation ability, immortalization / loss of contact inhibition / loss of anchorage dependency /deterioration of cellular adhesiveness / cell membrane alteration / tumor antigen (carcinoembryonic antigen, carbohydrate tumor antigen) B. Multistage carcinogenesis C. Oncogene and tumor suppressor gene: the history of their discovery 1) carcinogenesis and gene variation, gene defects: radiation, carcinogen / cancer virus ( Rous sarcoma virus) 2) oncogene, unified theory of ...

  [272] Cancer Detection Guide
      PDF [439,3 KB]  From [www.nfcr.org]  Last viewed: 07.09.2006
Cancer Detection Guide 1. As a minimum, includes history, physical exam, blood/urine laboratory tests and chest x-ray as determined by your physician. 2. Annual screening should be offered to individuals beginning at age 35 who belong to high-risk groups, defined as women with or at risk for hereditary nonpolyposis colorectal cancer (HNPCC). Women at average risk should be informed of the early symptoms of endometrial cancer and report any unexpected bleeding or spotting to their physicians. 3. Proctosigmoidoscopy – colon/rectal exam 4. Those in high-risk categories should begin at age 45. National Foundation for Cancer Research, 4600 East West Highway, Suite 525, Bethesda, MD 20814, www.NFCR.org I-5331-1204 AGE FREQUENCY FEMALES MALES 18-20 One time Complete Health Exam 1 Complete Health ...

  [273] Advocating for cervical cancer prevention
      PDF [107,5 KB]  From [www.womenshealth-elsevier.com]  Last viewed: 07.09.2006
ARTICLE Advocating for cervical cancer prevention J. Sherris a, T , I. Agurto b , S. Arrossi c , I. Dzuba d , L. Gaffikin e , C. Herdman a , K. Limpaphayom f , S. Luciani b a PATH, 1455 NW Leary Way, Seattle, WA 98107, USA b PAHO (Pan American Health Organization), Washington, DC, USA c International Agency for Research on Cancer (IARC), Lyon, France d EngenderHealth, New York, NY, USA e JHPIEGO, Baltimore, MD, USA f Department of Obstetrics/Gynaecology, Faculty of Medicine, Chulalongkhorn University, Bangkok, Thailand Abstract Cervical cancer is asignificant health problem among women in developing countries. Contributing to the cervical ...

  [274] Preventing cervical cancer in low-resource settings: Building a ...
      PDF [53,0 KB]  From [www.womenshealth-elsevier.com]  Last viewed: 07.09.2006
EDITORIAL Preventing cervical cancer in low-resource settings: Building a case for the possible Historical progress in the reduction of morbidity and mortality from cervical cancer has been attributed to systematic screening programs in wealthy countries—an option that has long seemed out of reach for poorer countries. Recent develop- ments suggest, however, that there is new hope for bringing cervical cancer under control, even in countries with limited financial and infrastructural resources. References to cervical cancer appear as early as the fifth century BC, in Greek and Hindu texts, but more complete descriptions of the disease and its treatment first appear in various medical texts in the 19th century [1] . In 1900, Cullen introduced the concept that precursor lesions were harbingers of cancer of the cervix [2] . Over the course of the next ...

  [275] Preventing cervical cancer in low-resource settings: How far have ...
      PDF [73,3 KB]  From [www.womenshealth-elsevier.com]  Last viewed: 07.09.2006
ARTICLE Preventing cervical cancer in low-resource settings: How far have we come and what does the future hold? V.D. Tsu a, T , A.E. Pollack b a Program for Appropriate Technology in Health (PATH), 1455 NW Leary Way, Seattle, WA 98107-5136, USA b EngenderHealth, New York, NY, USA Abstract The Alliance for Cervical Cancer Prevention (ACCP) came together in 1999 to answer key research questions and to advocate for greater global and national interest in reducing the heavy burden of morbidity and mortality caused by this preventable disease. Visual inspection with acetic acid (VIA), visual inspection with Lugol’s iodine (VILI), and human papillomavirus (HPV) tests have been shown to be viable alternatives to traditional cytology. ACCP experience confirmed that cryotherapy is a safe and effective method that is acceptable ...

  [276] Delivering cervical cancer prevention services in low-resource ...
      PDF [116,6 KB]  From [www.womenshealth-elsevier.com]  Last viewed: 07.09.2006
ARTICLE Delivering cervical cancer prevention services in low-resource settings J. Bradley a, T , M. Barone a , C. Mahé b , R. Lewis c , S. Luciani d a EngenderHealth, 440 Ninth Avenue, New York, NY 10001, USA b International Agency for Research on Cancer (IARC), Lyon, France c JHPIEGO, Baltimore, MD, USA d Pan American Health Organization (PAHO), Washington, DC, USA Abstract The goals of any cervical cancer prevention program should be threefold: to achieve high coverage of the population at risk, to screen women with an accurate test as part of high-quality services, and to ensure that women with positive test results are properly managed. This article focuses on the experiences of the Alliance for Cervical Cancer Prevention ...

  [277] Involving the community in cervical cancer prevention programs
      PDF [98,3 KB]  From [www.womenshealth-elsevier.com]  Last viewed: 07.09.2006
ARTICLE Involving the community in cervical cancer prevention programs I. Agurto a, * , S. Arrossi b , S. White a , P. Coffey c , I. Dzuba d , A. Bingham c , J. Bradley d , R. Lewis e a Pan American Health Organization (PAHO), 525 23rd Street, NW, Washington, DC 20037, USA b International Agency for Research in Cancer (IARC), Lyon, France c PATH, Seattle, WA, USA d EngenderHealth, New York, NY, USA e JHPIEGO, Baltimore, MD, USA Abstract Underutilization of cervical cancer prevention services by women in the high-risk age group of 30—60 years can be attributed to health service factors (such as poor availability, poor accessibility, and poor quality ...

  [278] Training for cervical cancer prevention programs in low-resource ...
      PDF [94,3 KB]  From [www.womenshealth-elsevier.com]  Last viewed: 07.09.2006
ARTICLE Training for cervical cancer prevention programs in low-resource settings: Focus on visual inspection with acetic acid and cryotherapy P.D. Blumenthal a,b, T , M. Lauterbach a , J.W. Sellors c , R. Sankaranarayanan d a JHPIEGO, Baltimore, 1615 Thames Street, Baltimore, MD 21231-3492, USA b Department of Gynecology and Obstetrics, Johns Hopkins University, Baltimore, MD, USA c PATH, Seattle, WA, USA d International Agency for Research on Cancer (IARC), Lyon, France Abstract The modern approach to cervical cancer prevention, characterized by use of cytology and multiple visits for diagnosis and treatment, has frequently proven challenging and unworkable in low-resource settings. Because of this, the Alliance for Cervical Cancer Prevention (ACCP) ...

  [279] Automated cancer diagnosis based on histopathological images: a ...
      PDF [804,6 KB]  From [www.cs.rpi.edu]  Last viewed: 07.09.2006
TECHNICAL REPORT, RENSSELAER POLYTECHNIC INSTITUTE, DEPARTMENT OF COMPUTER SCIENCE, TR-05-09. 1 Automated cancer diagnosis based on histopathological images: a systematic survey Cigdem Demir and Bulent Yener Abstract In traditional cancer diagnosis, pathologists examine biopsies to make diagnostic assessments largely based on cell morphology and tissue distribution. However, this is subjective and often leads to considerable variability. On the other hand, computational diagnostic tools enable objective judgments by making use of quantitative measures. This paper presents a systematic survey of the computational steps in automated cancer diagnosis based on histopathology. These computational steps are: 1.) image preprocessing to determine the focal areas, 2.) feature extraction to quantify the properties of these focal areas, and 3.) classifying the focal areas as malignant or not or identifying ...

  [280] Canadian Cancer Statistics 2005
      PDF [1024,5 KB]  From [www.cancer.ca]  Last viewed: 07.09.2006
For more information about breast health or breast cancer , call the Susan G. Komen Breast Cancer Foundation’s Toll-Free Helpline at 1.800 I’M AWARE ® (1.800.462.9273) or visit the Web site at www.komen.org. genetics & breast cancer Who has mutations in BRCA1 and BRCA2? The likelihood that you have mutations in the BRCA1 or BRCA2 genes is greater if one or more of the following statements is true for you: you are younger (below age 50) your mother, sister or daughter has had breast cancer before age 50 or ovarian cancer at any age a woman in your family has had both breast cancer and ovarian cancer a woman in your family has had breast cancer in both breasts your family is of Ashkenazi Jewish descent there is male breast cancer in your family Remember, most women who get breast cancer do not have an inherited gene mutation in ...

  [281] Diet and Cancer Prevention
      PDF [42,9 KB]  From [www.nutrition.org.uk]  Last viewed: 07.09.2006
Diet and Cancer Prevention Key points ? Cancer occurs when certain types of abnormal cells are produced. It can occur in different parts of the body ? A wide variety of factors are involved in the development of cancer . Some are related to family history, while others are related to lifestyle and diet. ? Avoiding smoking, eating a balanced diet with plenty of fruit and vegetables and moderate amounts of red and processed meats, keeping body weight within the healthy range for height and keeping alcohol consumption to a moderate level, all help to reduce the risk of cancer . What Is Cancer ? The body is made up of small units called cells. New cells are constantly produced to replace cells that have become worn out or damaged. New cells are also made during growth, e.g . during infancy and childhood. Normally, the body regulates the growth of new cells but occasionally ...

  [282] PERIOCULAR SKIN CANCER – Skin Tumors Around The Eye
      PDF [46,7 KB]  From [www.asoprs.org]  Last viewed: 07.09.2006
UPDATE MARCH 2004 European Association of Urology GUIDELINES ON TESTICULAR CANCER M.P. Laguna (Chairperson), O. Klepp, A. Horwich, F. Algaba, C. Bokemeyer, G. Pizzocaro, G. Cohn-Cedemark, P. Albers Page 2 TABLE OF CONTENTS PAGE 1 BACKGROUND 4 1.1 Methods 4 2 PATHOLOGY AND NATURAL HISTORY 4 3 DIAGNOSIS 5 3.1 Clinical examination 5 3.2 Imaging of the Testis 5 3.3 Serum Tumor Markers at diagnostic 5 3.4 Inguinal exploration and orchiectomy 6 3.5 Organ sparing surgery 6 3.6 Pathological examination of the testis 6 3.7 Diagnosis of Carcinoma in situ (Tin) 6 3.8 Screening 7 4 STAGING 7 4.1 Diagnostic tools 7 4.2 Serum tumour markers. Postorchiectomy ...

  [283] Texas Cancer Plan 2005: A statewide blueprint for cancer ...
      PDF [1586,9 KB]  From [www.tcc.state.tx.us]  Last viewed: 07.09.2006
3 2 Cellular Health Series: Cancer Matthias Rath, M.D. First Edition, February 2001 Cellular Health Series - Cancer . Copyright 2001 by Matthias Rath, M.D. All rights reserved. Published by MR Publishing, Inc., Santa Clara, CA 95054 No part of this book may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in critical articles or reviews. For information, address: This book is not intended as a substitute for the medical advice of a physician. The reader should regularly consult a physician in matters relating to his or her health and particularly in respect to any symptoms that may require diagnosis or medical attention. The authors and the publisher disclaim responsibility for any adverse effects resulting directly or indirectly from the information contained in this book. ...

  [284] Lung Cancer
      PDF [74,6 KB]  From [www.aghealth.org]  Last viewed: 07.09.2006
NC OFFICE • BATTELLE • CENTERS FOR PUBLIC HEALTH RESEARCH & EVALUATION 100 CAPITOLA DR, SUITE 301 • DURHAM, NC 27713 • 1-800-4AG-STUDY Lung Cancer Spring 2005 Lung Cancer Lung cancer is one of the most frequently diagnosed cancers in the world and is the leading cause of cancer death. Are participants in the Agricultural Health Study at increased risk for lung cancer ? Based on the current findings from the study, participants are significantly less likely – over 50% less likely – than other people in North Carolina and Iowa to be diagnosed with lung cancer . This is very good news for the farm population. Why do farmers, overall, have less lung cancer than the general population? There may be several reasons, but the main one is that farmers and their spouses smoke less than non-farmers. Overall, 14% of Agricultural ...

  [285] Incidence of Cancer
      PDF [85,2 KB]  From [www.aghealth.org]  Last viewed: 07.09.2006
NC OFFICE • BATTELLE • CENTERS FOR PUBLIC HEALTH RESEARCH & EVALUATION 100 CAPITOLA DR, SUITE 301 • DURHAM, NC 27713 • 1-800-4AG-STUDY Incidence of Cancer Spring 2005 Cancer Incidence From enrollment in the study through 2001, Agricultural Health Study participants were less likely to be diagnosed with cancer than other North Carolina and Iowa residents. Understanding the incidence of cancer and its causes among farmers, their spouses, and others who are licensed pesticide applicators is an important goal of the Agricultural Health Study. The design of the study—following a large number of healthy individuals into the future in a long-term and comprehensive way—sets the Agricultural Health Study apart from other studies and allows scientists to study the occurrence of cancer as the study population ...

  [286] Prostate Cancer
      PDF [94,3 KB]  From [www.aghealth.org]  Last viewed: 07.09.2006
NC OFFICE • BATTELLE • CENTERS FOR PUBLIC HEALTH RESEARCH & EVALUATION 100 CAPITOLA DR, SUITE 301 • DURHAM, NC 27713 • 1-800-4AG-STUDY Prostate Cancer Spring 2005 Prostate Cancer Prostate cancer is one of the diseases of particular interest to the Agricultural Health Study because it is the most common cancer among American men and because it has been reported in other studies to be high among farmers. Does research in the Agricultural Health Study indicate that pesticide applicators are at increased risk for prostate cancer ? Research in the Agricultural Health Study shows that the incidence of prostate cancer among licensed restricted-use pesticide applicators is slightly higher (14%) than it is for other men in North Carolina and Iowa. Risk factors observed in other studies—age and a family history of prostate ...

  [287] Ontario Cancer Treatment Practice Guidelines Initiative
      PDF [160,0 KB]  From [www.cancercare.on.ca]  Last viewed: 07.09.2006
Combined Modality Radiotherapy and Chemotherapy in the Non-surgical Management of Localized Carcinoma of the Esophagus Practice Guideline Report #2-12 Wong RKS, Malthaner RA, Zuraw L, Rumble RB, and members of Cancer Care Ontario’s Program in Evidence-based Care’s Gastrointestinal Cancer Disease Site Group. ORIGINAL GUIDELINE: April 17, 2002 MOST RECENT LITERATURE SEARCH: February 10, 2005 NEW EVIDENCE ADDED TO GUIDELINE REPORT: June 26, 2003 New evidence found by update searches since completion of the original guideline is consistent with the original recommendations. SUMMARY Guideline Question Does combined modality radiotherapy and chemotherapy improve survival compared with radiotherapy alone in patients with localized carcinoma of the esophagus for whom a non-surgical approach is used? Target Population These recommendations apply to adult patients ...

  [288] final cancer
      PDF [719,7 KB]  From [www.public-health.uiowa.edu]  Last viewed: 07.09.2006
1 2005 C A N C E R I N I OWA R E POR T Prostate Cancer in Iowa S TAT E H E A L T H R E G I S T R Y O F I OW A Page 2 2 I n 2005, an estimated 6,500 Iowanswilldie from cancer , 15 times the number caused byauto fatalities. Cancer issecond onlyto heart disease asa cause ofdeath. These projectionsare based upon mortalitydatathe State Health RegistryofIowareceivesfrom the IowaDepartmentofPublicHealth. The Registryhasbeen recording the occurrence ofcancer in Iowasince 1973, and isone offourteen registriesnationwide providing datatothe NationalCancer Institute. With 2005 Cancerin Iowa the Registrymakesa generalreportto the publicon the statusofcancer. Thisreportwillfocuson: •adescription ofthe Registryand itsgoals; • cancer estimatesfor ...

  [289] Ontario Cancer Treatment Practice Guidelines Initiative
      PDF [585,9 KB]  From [www.cancercare.on.ca]  Last viewed: 07.09.2006
Combined Modality Radiotherapy and Chemotherapy in the Non-surgical Management of Localized Carcinoma of the Esophagus Practice Guideline Report #2-12 Wong RKS, Malthaner RA, Zuraw L, Rumble RB, and members of Cancer Care Ontario’s Program in Evidence-based Care’s Gastrointestinal Cancer Disease Site Group. ORIGINAL GUIDELINE: April 17, 2002 MOST RECENT LITERATURE SEARCH: February 10, 2005 NEW EVIDENCE ADDED TO GUIDELINE REPORT: June 26, 2003 New evidence found by update searches since completion of the original guideline is consistent with the original recommendations. SUMMARY Guideline Question Does combined modality radiotherapy and chemotherapy improve survival compared with radiotherapy alone in patients with localized carcinoma of the esophagus for whom a non-surgical approach is used? Target Population These recommendations apply to adult patients ...

  [290] NAO Report (HC 343 2004-05) The NHS Cancer Plan: A Progress Report ...
      PDF [613,3 KB]  From [www.nao.org.uk]  Last viewed: 07.09.2006
Evidence-based Series #2-15: Section 1 Oral Capecitabine (Xeloda ) in the First-line Treatment of Metastatic A Clinical Practice Guideline W Koc intestinal Cancer Disease ence-based Care. the Program in Evidence-based Care (PEBC), Cancer Care Ontario (CCO) Developed by the Gastrointestinal Cancer Disease Site Group 11, 2005 ent of patients ther thymidylate st, and time-to- ion er, who have not notherapy with nts who are at a erapy, adjuvant diagnosed with Recommendations • In appropriate patients, standard combination chemotherapy consists of infusional 5- fluouracil plus leucovorin calcium with either irinotecan or oxaliplatin (refer to the Program in Evidence-based Care’s Practice Guideline #2-16b: Use of Irinotecan (Camptosar®, CPT-11) Combined with 5-fluorouracil and Leucovorin (5FU/LV) as First-line ...

  [291] Michigan Cancer Consortium
      PDF [55,7 KB]  From [www.michigancancer.org]  Last viewed: 07.09.2006
Michigan Cancer Consortium Guidelines for the Early Detection of Colorectal Cancer February 2, 2005 Recommendations for Colorectal Cancer Screening (Table 1) Based on Guidelines of the American Cancer Society (2004), the U.S. Multisociety Task Force (2003), and the U.S. Preventive Services Task Force (2002) • If patient reports rectal bleeding a diagnostic evaluation is recommended (See Table 3.) • Screening should continue regardless of age; however, discontinuing screening is reasonable in patients whose age or comorbid conditions limit life expectancy. Table 1 AVERAGE RISK Risk Category Recommendation 1 Age to Begin Interval All people ages 50 and over not in the categories below - Fecal occult blood test (FOBT) * - Flexible sigmoidoscopy (FS) - Flexible sigmoidoscopy plus FOBT ...

  [292] P5_TA(2003)0270 Breast cancer
      PDF [96,3 KB]  From [www.epgbc.org]  Last viewed: 07.09.2006
P5_TA(2003)0270 Breast cancer European Parliament resolution on breast cancer in the European Union (2002/2279(INI)) The European Parliament , – having regard to Article 152 of the EC Treaty as amended by the Treaty of Nice, – having regard to Article 35 of the Charter of Fundamental Rights of the European Union 1, – having regard to its resolution of 9 March 1999 on the report from the Commission to the Council, the European Parliament, the Economic and Social Committee and the Committee of the Regions on the state of women’s health in the European Community 2, – having regard to its resolution of 13 February 2003 on the Commission communication on Community and national measures in relation to breast implants 3 , – having regard to its resolution of 4 October 2001 on the patenting of BRCA1 and BRCA2 breast cancer genes ...

  [293] Ovarian Cancer
      PDF [185,1 KB]  From [www.wellbeingofwomen.org.uk]  Last viewed: 07.09.2006
Ovarian Cancer Page 2 WellBeing of Women Funding Vital Health Research WellBeing of Women is about life – helping enable it, sustain it and make it the best quality. Women are the motivating factor for us and our aim is for women everywhere to be free of fear and suffering from reproductive problems. Our determination to meet the health needs of women today is as strong as it was in 1964 when the charity started. WellBeing of Women is dedicated to the challenge of raising greater awareness and securing more support and funds to invest in new medical research in three key areas of reproductive health: G Gynaecological Cancers G Pregnancy and Birth G Quality of Life problems If you would like to know more about WellBeing of Women , please contact us at: WellBeing of Women 27 Sussex Place ...

  [294] Colorectal Cancer Facts & Figures
      PDF [595,9 KB]  From [www.cancer.org]  Last viewed: 07.09.2006
Estimated New Cancer Cases and Deaths by Sex for All Sites, US, 2004 * Estimated New Cases Estimated Deaths Both Sexes Male Female Both Sexes Male Female All sites 1,368,030 699,560 668,470 563,700 290,890 272,810 Oral cavity & pharynx 28,260 18,550 9,710 7,230 4,830 2,400 Tongue 7,320 4,860 2,460 1,700 1,100 600 Mouth 10,080 5,410 4,670 1,890 1,070 820 Pharynx 8,250 6,330 1,920 2,070 1,460 610 Other oral cavity 2,610 1,950 660 1,570 1,200 370 Digestive system 255,640 135,410 120,230 134,840 73,240 61,600 Esophagus 14,250 10,860 3,390 13,300 10,250 3,050 Stomach 22,710 13,640 9,070 11,780 6,900 4,880 ...

  [295] SCIENCE AND TECHNOLOGY COMMITTEE – Inquiry into access to ...
      PDF [7,7 KB]  From [www.wcrf.org]  Last viewed: 07.09.2006
SCIENCE AND TECHNOLOGY COMMITTEE – Inquiry into access to scientific publications World Cancer Research Fund International The World Cancer Research Fund global network comprises WCRF International and its member organisations – national charities based in different countries (in the USA – AICR; in the UK – WCRF UK; in the Netherlands – WCRF NL; in Germany – WCRF DE; and in Hong Kong – WCRF HK). The WCRF global network has the unique role of translating scientific data into global health recommendations. These health recommendations not only inform the public on cancer prevention, but they also help to set the agenda for future cancer research and national health policies. Background In 1997, WCRF (World Cancer Research Fund) and its affiliate in the USA, AICR (American Institute for Cancer Research) jointly published the ground breaking report, Food, Nutrition and the Prevention of Cancer ...

  [296] Cancer Care Ontario Practice Guidelines Initiative
      PDF [167,3 KB]  From [www.cancercare.on.ca]  Last viewed: 07.09.2006
Postoperative Adjuvant Radiation Therapy in Stage II or IIIA Completely Resected Non-Small Cell Lung Cancer Practice Guideline Report #7-1-1 G. Okawara, Y.C. Ung, B.R. Markman, J.A. Mackay, W.K. Evans, and members of the Lung Cancer Disease Site Group ORIGINAL GUIDELINE: September 10, 2002 MOST RECENT LITERATURE SEARCH: January 2005 NEW EVIDENCE ADDED TO REPORT: February 2005 New evidence found by update searches since the completion of the original guideline is consistent with the original recommendations. This practice guideline report, together with a companion report on postoperative adjuvant chemotherapy with or without radiotherapy in completely resected non-small cell lung cancer (PG #7-1-2, currently under development), replaces: Practice Guideline Report #7-1: Postoperative Adjuvant Chemotherapy and/or Radiation Therapy in Stage II or IIIA Completely Resected ...

  [297] Cancer Facts & Figures for AfricanAmericans 2005-2006
      PDF [548,8 KB]  From [www.cancer.org]  Last viewed: 07.09.2006
AMERICAN CANCER SOCIETY INSTITUTIONAL RESEARCH GRANTS POLICIES & INSTRUCTIONS Effective January 2006 AMERICAN CANCER SOCIETY, INC. Extramural Grants Department 1599 Clifton Road, N.E. Atlanta, Georgia 30329-4251 Voice: (404) 329-7558 Fax: (404) 321-4669 Web site: http://www. cancer .org Email: grants@ cancer .org MISSION The American Cancer Society is the nationwide, community-based, voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer , saving lives and diminishing suffering from cancer through research, education, advocacy, and service. Page 2 General Policies - January 2006 2 AMERICAN CANCER SOCIETY EXTRAMURAL GRANTS POLICIES CONTENTS 1. OVERVIEW OF THE EXTRAMURAL GRANTS PROGRAM OF THE AMERICAN ...

  [298] Cancer and the Environment: A Case for the Precautionary Principle ...
      PDF [480,3 KB]  From [www.hbcac.org]  Last viewed: 07.09.2006
The New York State Breast Cancer Network advocates for the adoption of the Precautionary Principle in guiding public policy and planning in New York State and urges its incorporation into all relevant legislative, administrative, and regulatory activities. Let's face the alarming facts about cancer incidence rates in New York State. Our state places third in total cancer incidence rates for men and women and second in breast cancer incidence rates in the US. Unfortunately, cancer strikes children as well as adults. Incidence rates of all childhood cancers have risen nearly 21% between 1975 and 1998, with genetic factors accounting for only one-fifth of these cases. We cannot blame genetics for causing adult cancers either; to give just one example, genetic mutation accounts for only 5-10% of all breast cancer cases. Research over the last two decades has revealed that ...

  [299] Age-Adjusted Cancer Death Rates, Females by Site, US, 1930-2001
      PDF [28,5 KB]  From [www.cancer.org]  Last viewed: 07.09.2006
For more information call toll free: 1-800-ACS-2345 or on the Internet, http://www. cancer .org National Home Office: American Cancer Society, Inc., 1599 Clifton Road NE, Atlanta, GA 30329-4251, (404) 320-3333 National Media Office: 1180 Avenue of the Americas, New York, NY 10036, (212) 382-2169 ©1997, American Cancer Society, Inc. 97-300M-No. 5008.97 The American Cancer Society is the nationwide, community-based, voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer , saving lives and diminishing suffering from cancer , through research, education, advocacy, and service. Page 2 S pecial S ection: RA CIAL AND ETHNI C P A T TER N S Estimated number of new cancer cases in 1997 by state, total: 1,382,400 (excluding Puerto ...

  [300] Cancer Facts & Figures
      PDF [1821,9 KB]  From [www.cancer.org]  Last viewed: 07.09.2006
Breast Cancer Facts & Figures 2001-2002 Page 2 Table of Contents What is breast cancer ? 1 Who gets breast cancer ? 1 How has the occurrence of breast cancer changed over time? 3 What factors influence breast cancer survival? 5 What are the known risk factors for breast cancer ? 7 Can breast cancer be prevented? 9 How can breast cancer be detected early? 10 How is breast cancer treated? 11 What research is currently being done on breast cancer ? 14 What resources are available in your community? 15 What is the American Cancer Society doing about breast cancer ? 16 Sources of Statistics 17 References 18 Acknowledgments The production of this report would not have been possible without the efforts of: Cheryll Cardinez, MSPH, Vilma Cokkinides, PhD, ...